CDK4/6 is crucial for the G1- to S-phase transition and abnormalities in CDK4/6 and the NF1 (a negative regulator of RAS activity) gene may contribute to neuroblastoma and malignant peripheral nerve sheath tumors. This evidence concerns the gene CDK4 and neuroblastoma.